Embed Size (px)
Citation preview
Health literacy interventions at the
service delivery/institutional level:
country examples
Amy Israel
Global Health Thought Leadership & Policy Director
Eli Lilly
on behalf of International Federation of Pharmaceutical
Manufacturers & Associations (IFPMA)
•
2
OPERATING
PRINCIPLE
DISEASE AREAS
INTERVENTION
AREAS
2
Diabetes Cancer MDR-TB Apply learnings,
ensure linkages
GEOGRAPHIES
WE ASPIRE TO FUNDAMENTALLY CHANGE CARE IN RESOURCE-LIMITED SETTINGS
Develop patient-centered models to expand access to care
and improve outcomes closer to the primary care level in
resource-limited settings
Design chronic care models for community and
primary health care settings
Advocate for scaling up successful models and
implementing policies changes to improve access
to chronic care
3
Brazil
China
India
Kenya
Mexico
Russia
South
Africa
United
States
Enhancing capacity at primary care level for early diagnosis and
management of diabetes and cancer
Developing a model to improve treatment demand and access to
care through provider and nurse training
Building on diabetes and TB learnings to prove a treatment adherence and
support model in public and private settings for diabetes and hypertension.
Testing innovative models of care to support early detection and
treatment for breast and cervical cancers
Supporting the national implementation of CASALUD primary care model
and using system-wide data for improving diabetes care in the country’s two
largest health systems
Bringing TB levels down in one oblast to that seen in Western Europe, and
developing a model of care for diabetes focusing on the role of the primary
care physician
Piloting new ways of improving diabetes prevention and care
through a neighborhood-based approach in Indianapolis, Indiana
Expanding diabetes care model to integrate HIV, TB, maternal and child
health; building on our tuberculosis efforts to overlay diabetes hypertension
care onto TB treatment programs
NEXT FIVE YEARS: EIGHT COUNTRIES AND THREE DISEASES
DIABETES
CANCER
MDR-TB
4
TARGETING SPECIFIC PAIN POINTS ALONG PATHWAYS OF CARE
LTFU=Loss-to-follow-up
Program intervention
Program intervention
Program Intervention
5
Diabetes
Improved access to diabetes care in Mexico through a comprehensive primary care model. Adherence to
treatment increased with more than 70% of patients in two states participating in support groups. National
rollout of this model is underway.
Identified over 70,000 people with diabetes or hypertension in India and developed information, education
and communication materials now being adopted by the Ministry of Health.
Developed and tested primary care guidelines and provider training toolkit and a type 1 diabetes toolkit for
providers, parents and children in Brazil, which are now being considered for broader rollout by the Ministry
of Health.
Tested community-based diabetes and hypertension screening approaches in South Africa, providing data on
both the prevalence of these conditions and loss-to-follow-up between screening and treatment initiation.
IMPACT TO DATE
6
We are tracking a standardized set of indicators across programs which are
focused on the pain points along the patient pathway we are working to
address, including:
SHARING PROGRESS AND LEARNINGS ALONG THE WAY
Outputs Outcomes
# individuals with controlled diabetes
# individuals with controlled
hypertension
# individuals implementing lifestyle
change by meeting recommended
levels of physical activity, dietary
changes
# Individuals screened
# Individuals diagnosed
# Individuals on treatment
# Facilities activated to provide screening,
diagnosis and treatment services
Integrating diabetes and hypertension care into TB platforms
Case Study in Chennai
Chennai
INDIA
Private sector health care providers are critical to reaching people
Interventions at the Nakshatra Center
Private health sector engagement for integration
Integrated healthcare delivery for patients in the private sector
Diabetes & Hypertension Screening & Diagnosis
TB patient TB symptoms Household contacts
TB Screening & diagnosis
Health literacy interventions at the
service delivery/institutional level:
country examples
Amy Israel
Global Health Thought Leadership & Policy Director
Eli Lilly
on behalf of International Federation of Pharmaceutical
Manufacturers & Associations (IFPMA)
•
